Abstract
The goal of this study was to examine, the relationship between chronic kidney disease (CKD) and glaucomatous optic disc neuropathy in a cohort of patients from the south-east Serbia and to determine whether limited screening for glaucoma in specific subgroups of patients with CKD is reasonable and justifiable. This cross-sectional study included 328 subjects with various stages of CKD. All patients had visited the Outpatient Department of the Nephrology Clinic, Clinical Center Nis, Serbia. All patients underwent routine ophthalmic examinations. Glaucoma diagnosis based on elevated intraocular pressure (IOP), the presence of excavation of the optic nerve head (C/D ratio), and characteristic glaucomatous visual field loss (MD—mean deviation, PSD—pattern standard deviation). CKD was defined as kidney damage or glomerular filtration rate (GFR) of <60 ml/min/1.73 m2 for >3 months. A total number of 328 CKD patients, 33 (10.1 %) with primary open angle glaucoma and 28 (8.5 %) with ocular hypertension (OH), were included in the study. Patients with CKD and glaucoma had significantly higher mean values of C/D ratio (0.59), visual field mean deviations (dB)—MD (p < 0.001), and visual field pattern standard deviations (dB)—PSD (p < 0.001) than patients with CKD and OH. Stepwise multivariate linear regression analysis confirmed that the most significant factors related to IOP are age (p < 0.05), AHT (p = 0.01), and eGFR (p = 0.001). Multivariate regression analysis also confirmed that the most significant factors related to cup-to-disc ratio are number of years of smoking (p < 0.05), AHT, and sCr (p < 0.01). In conclusion, the prevalence of glaucoma among CKD patients in the cohort from south-east Serbia is 10.1 %. Patients with CKD and glaucoma, eGFR and current cigarette smoking are associated with IOP level, MD, and PSD of visual field and C/D ratio.
Similar content being viewed by others
References
Hallan SI, Dahl K, Oien CM, Grootendorst DC, Aasberg A, Holmen J, Dekker FW (2006) Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 333(7577):1047
Vassalotti JA, Stevens LA, Levey As (2007) Testing for chronic kidney disease: a position statement from the National Kidney Foundation. Am J Kidney Dis 50(2):169–180
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS (2007) Prevalence of chronic kidney disease in the United States. JAMA 298(17):2038–2047
McClellan W, Warnock DG, McClure L, Campbell RC, Newsome BB, Howard V, Cushman M, Howard G (2006) Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephro l 7(6):1710–1715
Evans RD, Rosner M (2005) Ocular abnormalities associated with advanced kidney disease and hemodialysis. Semin Dial 18(3):252–257
Nongpiur ME, Wong TY, Sabanayagam C, Lim SC, Tai ES, Aung T (2010) Chronic kidney disease and intraocular pressure:the Singapore Malay Eye Study. Ophthalmology 117(3):477–483
Jalel T, Faouzi H, Faten T, Abdellatif A, Mahdouani K (2005) Ocular complications in peritoneal haemodialysis. Tunis Med 83(10):617–621
Song WK, Ha SJ, Yeom HY, Seoung GJ, Hong YJ (2006) Recurrent intraocular pressure elevation during hemodialysis in a patient with neovascular glaucoma. Korean J Ophthalmol 20(2):109–112
Tawara A, Kobata H, Fujisawa K, Abe T, Ohnishi Y (1998) Mechanism of intraocular pressure elevation during hemodialysis. Curr Eye Res 17(4):339–347
Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C (2008) Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog Brain Res 173:3–14
Wong CW, Wong TY, Cheng CY, Sabanayagam C. Kidney and eye diseases: common risk factors, ethiological mechanisms, and pathways. Kidney International advance online publication, December 2013
Foster PJ, Buhrmann R, Quigley HA, Johnson GJ (2002) The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86(2):238–242
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO (2002) The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):701–713
Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G (2005) Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 67(6):2089–2100
Nakamura M, Kanamori A, Negi A (2005) Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 219(1):1–10
Lee AJ, Rochtchina E, Wang JJ, Healey PR, Mitchell P (2003) Does smoking affect intraocular pressure? Findings from the Blue Mountains Eye Study. J Glaucoma 12(3):209–212
Grunwald JE, Alexander J, Maguire M, Whittock R, Parker C, McWilliams K, Lo JC, Townsend R, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman H, Kusek J, Ojo A, CRIC Study Group (2010) Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol 5(5):867–873
Vaziri ND (2004) Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens 3(1):93–99
Gabelt BT, Kaufman PL (2005) Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 24(5):612–637
De Marchi S, Cecchin E, Tesio F (1989) Intraocular pressure changes during hemodialysis: prevention of excessive dialytic rise and development of severe metabolic acidosis following acetazolamide therapy. Ren Fail 11(2–3):117–124
Konta T, Hao Z, Abiko H, Ishikawa M, Takahashi T, Ikeda A, Ichikawa K, Takasaki S, Kubota I (2006) Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 70(4):751–756
Costa VP, Arcieri ES, Harris A (2009) Blood pressure and glaucoma. Br J Ophthalmol 93(10):1276–1282
Dielemans I, Vingerling JR, Algra D, Hofman A, Grobbee DE, de Jong PT (1995) Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: the Rotterdam Study. Ophthalmology 102(1):54–60
Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR (1977) The Framingham eye study. I. Outline and major prevalence findings. Am J Epidemiol 106(1):17–32
Tuck MW, Crick RP (1998) The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol 5(4):173–183
Hollands H, Johnson D, Hollands S, Simel DL, Jinapriya D, Sharma S (2013) Do findings on routine examination identify patients at risk for primary open-angle glaucoma? The rational clinical examination systematic review. JAMA 309(19):2035–2042
Topouzis F, Wilson MR, Harris A, Anastasopoulos E, Yu F, Mavroudis L, Pappas T, Koskosas A, Coleman AL (2007) Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmo l44(4):511–519
Acknowledgments
This work was supported by a Grant No 175092 from the Ministry of Education, Science and Technological Development of Serbia.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Djordjevic-Jocic, J., Cukuranovic, R., Mitic, B. et al. Ocular and systemic factors associated with glaucoma in chronic kidney disease patients. Int Urol Nephrol 46, 2191–2198 (2014). https://doi.org/10.1007/s11255-014-0804-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-014-0804-0